scholarly article | Q13442814 |
P953 | full work available at URL | http://www.jimmunol.org/cgi/content/abstract/129/6/2763 |
P698 | PubMed publication ID | 6183343 |
P2093 | author name string | Roehrig JT | |
Mathews JH | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
monoclonal antibody | Q422248 | ||
P304 | page(s) | 2763-2767 | |
P577 | publication date | 1982-12-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies | |
P478 | volume | 129 |
Q55400521 | A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encepha |
Q41230818 | Antibody to the E3 Glycoprotein Protects Mice against Lethal Venezuelan Equine Encephalitis Virus Infection |
Q27486798 | Antibody-selected variation and reversion in Sindbis virus neutralization epitopes |
Q27486021 | Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein |
Q27490878 | Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB |
Q27486900 | Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV) |
Q36525351 | Early activation of the host complement system is required to restrict central nervous system invasion and limit neuropathology during Venezuelan equine encephalitis virus infection |
Q40478209 | Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins. |
Q72362078 | Enhanced protection against respiratory influenza A infection in mice by liposome-encapsulated antibody |
Q37466235 | Humanized antibodies for antiviral therapy |
Q36797624 | Identification of antigenically important domains in the glycoproteins of Sindbis virus by analysis of antibody escape variants |
Q36895841 | Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities |
Q27684308 | Locking and Blocking the Viral Landscape of an Alphavirus with Neutralizing Antibodies |
Q27486929 | Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus |
Q44269741 | Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis |
Q39726309 | Monoclonal antibodies: implications for virology. Brief review |
Q27486805 | Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice |
Q36892657 | Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo |
Q36864332 | Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice |
Q36898964 | Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis |
Q27486835 | Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge |
Q27480856 | Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus |
Q37035495 | Resistance to adenovirus infection after administration of Bordetella pertussis vaccine in mice |
Q27486933 | Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies |
Q91631072 | Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice |
Q36856960 | Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors |
Q27860954 | The alphaviruses: gene expression, replication, and evolution |
Q40201291 | The application of monoclonal antibodies in the study of viruses. |
Q33991546 | The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity |
Q27473170 | The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus |
Q91605138 | Therapeutic monoclonal antibody treatment protects nonhuman primates from severe Venezuelan equine encephalitis virus disease after aerosol exposure |
Q34991116 | Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection |
Search more.